SPL (ASX) Track Record

Originally posted by antibotter: ↑

Starpharma have so far been quite disappointing in the way it has commercialised products

The Vivagel condom
A dismal failure so far
It had been approved for sale in Canada and Australia and New Zealand. But guess what.......you cannot buy our condoms in any of the above jurisdictions. I will not give you a history lesson. It is too depressing to talk about. Just to say that the historical and current partnership agreements in place have produced nada in sales with the exception of Japan

The Vivagel BV gel
Well just look at one of our partners, Mundipharma. What has it done. Certainly nothing that I can see. Even a suggestion of using online social media sites such as Facebook has not been taken advantage of. How hard can it be to market online. There has been suggestions of using a webstore. Starpharma has a webstore which sells Viraleze nasal spray. Why not used it for Vivagel condoms and BV Gel as well. One stop shop. Of course it could be embedded in relevant websites such as government platforms. Which brings me to the point of why haven't these sites been updated to bring awareness to sufferers of BV, of alternative remedies such as our non antibiotic solution

Talking about the three years plus since Starpharma signed a US$101 million deal with a licensee to sell into the USA our BV Gel, and a first refusal from FDA for our NDA has really been the hardest thing to understand. Changing of the staff last minute and then COVID coming along to derail the procedure (according to Starpharma) and then secondment by those at the FDA working on the approval to other areas really begs the question of REALLY.

Okay so there you have it

y

So where are we today

The condom business will not generate any income. Just a further point......way back whwn....the Starpharma condom coating (SPL 7013) was going to be put on all condoms marketed by the first licensee. Wouldn't that be nice. Alas the licensee was bought out and this project never eventuated

The Vivagel BV Gel just needs to be marketed properly and then you will start to see some real revenue being generated

The Viraleze Nasal Spray
In the beginning it was a roaring success and tipped to make our company cash flow positive in calendar year 2021
Whether it was politics or third parties interfering in this success story is irrelevant. It was taken off the shelves in UK and is yet to be approved in Australia (hopefully this will change in February)

Hopefully we will see it back on shelves in UK shortly as well

The Indian deal is still alive

It was touted that Bayer was going to be Starpharma's global licensee for the Viraleze nasal spray. Is this deal dead. Only time will tell. Was it a coincidence that Bayer was mentioned in the Saudi deal or not

Our oncology drug delivery program is going great guns

We have three in house drugs coming to end of their phase 2 trials with reporting expected for all of them before end of financial year

We have multiple partners...... disclosed and undisclosed going full speed ahead with our drug delivery program

We have multiple drugs in preclinical trials..........and with a couple of those going into in house trials soon

We have an ADC's and novel radiotherapeutic and radiodiagnostic drug delivery platform which new partners will be signed up to

We will have a milestone payment coming in for initiation of phase 2 of the seamless phase 1/2 AZD0466 trial

Many posters ask.........why is our CEO so secretive........well that is the nature of the game........

I am fed up with the belittling of posters on this forum

Enough please

Grow up

I look forward to some very positive announcements this month

Expand

Much of the later parts of your post are completely false and misleading. You should back up those statements with facts, not masquerading musings and assumptions as facts. Very disappointing, again.

No.	Vol.	Price($)
1	283879	12.0¢

No.

Vol.

Price($)

283879

12.0¢

Price($)	Vol.	No.
12.5¢	145922	4

Price($)

Vol.

No.

12.5¢

145922

No.	Vol.	Price($)
1	283879	0.120
10	763628	0.115
8	214533	0.110
8	272642	0.105
11	304483	0.100

No.

Vol.

Price($)

283879

0.120

763628

0.115

214533

0.110

272642

0.105

304483

0.100

Price($)	Vol.	No.
0.125	145922	4
0.130	272057	8
0.135	65776	5
0.140	128797	9
0.145	200605	6

Price($)

Vol.

No.

0.125

145922

0.130

272057

0.135

65776

0.140

128797

0.145

200605

(20min delay)
Last 12.5¢		Change 0.005(4.17%)		Mkt cap ! $51.50M

Open	High	Low	Value	Volume
12.0¢	12.5¢	11.5¢	$96.08K	801.0K


Last 12.0¢		Change 0.005 ( 4.00 %)
Open	High	Low	Volume
12.0¢	12.0¢	11.5¢	206768
Last updated 15.59pm 08/05/2024 ?

Track Record, page-2

Featured News

Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production

Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Tamboran is listing on the NYSE, and Wall Street is paying attention

Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne

Buyers (Bids)

Sellers (Offers)

Featured News

Track Record, page-2

Featured News

Top Stories

Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production

Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Tamboran is listing on the NYSE, and Wall Street is paying attention

Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne

Buyers (Bids)

Sellers (Offers)

Featured News